The present invention relates generally to medical devices and, more specifically, to intramedullary implants.
Total hip replacement has become a common orthopedic procedure. While short term complications have been minimized, long term complications still occur frequently. Periprosthetic osteolysis is the most significant long-term complication. Periprosthetic osteolysis is the process of progressive destruction of periprosthetic bony tissue, which can lead to loosening and catastrophic failure of the implant.
One cause of periprosthetic osteolysis is adaptive bone remodeling or stress shielding that occurs in response to an altered mechanical environment in the bones receiving the implant. Adaptive bone remodeling occurs because there is a redistribution of load, and therefore stress, when the implant component, typically composed of a material harder than the natural bone, is inserted into the bone. In many cases, the stress on the proximal portion of the bone is lessened. It is believed that most of the load bypasses this area and is transmitted through the metal stem to the distal femur. The reduced load on the proximal portion leads to osteolysis, which, in turn can lead to losing or failure of the implant.
It is desirable to provide an improved intramedullary implant that more evenly distributes stress through the bone, leading to less loosening of the implant.
Various embodiments of implant systems and related apparatus, and methods of operating the same are described herein. In various embodiments, an implant for interfacing with a bone structure includes a web structure, including a space truss, configured to interface with human bone tissue, including cells, matrix, and ionic milieu. The space truss includes two or more planar truss units having a plurality of struts joined at nodes.
In an embodiment, an osteo-integrated intramedullary implant comprises: an intramedullary body, insertable into the medullary cavity of a bone, comprising one or more outer contact faces; and a space truss coupled to the outer contact faces, wherein, during use, the space truss is at least partially disposed inside medullary cavity, between the intramedullary body of the implant and the medullary cavity, wherein the space truss comprises two or more planar truss units having a plurality of struts joined at nodes. In an embodiment, a diameter and/or length of the struts and/or density of the web structure are predetermined such that when the web structure is in contact with the bone at least a portion of strain on the intramedullary rod is distributed through the web structure to the bone.
The diameter and/or length of the struts and/or the density of the space truss are predetermined such that when the space truss is in contact with the bone structure, its matrix, or the cells from which it is derived, at least a portion of the struts create a microstrain, that is transferred to the adherent osteoblasts, bone matrix, or lamellar tissue, of between about 1με and about 5000με, or between about 500με and 2000με, or between about 1000με and about 1500με or to a negative reflection of compression in interval and resonance with loading in both flexion, extension, torque, or combinations thereof. These ranges are optimized to known load-response dynamics, but are meant as guides rather than limitations to the activity and response. The diameter and/or length of the struts is predetermined so that at least a portion of the struts during loading create a change in length of the adherent osteoblasts, bone matrix, or lamellar tissue, of between about 0.05% and about 0.2% or between about 0.1% and about 0.15% causing an osteogenic response. Struts may have a length of between about 1 mm to about 100 mm. The diameter of the strut may be predetermined such that the struts create a change in length of the adhered osteoblasts of between about 0.05% and 0.2% when the web structure is in contact with the bone structure. Alternatively, the diameter of the strut is predetermined such that the strut undergoes a change of length of between about 0.000125% and 0.0005%. or between about 0.00025% and 0.000375%. In some embodiments, at least a portion of the struts are composed of struts having a length of 1 mm to 100 mm and a diameter ranging between 0.250 mm and 5 mm.
In an embodiment, an osteo-integrated intramedullary implant comprises: an intramedullary body, insertable into the medullary cavity of a bone, comprising one or more outer contact faces; and a space truss coupled to the outer contact faces, wherein, during use, the space truss is at least partially disposed inside medullary cavity, between the intramedullary body of the implant and the medullary cavity, wherein the space truss comprises two or more planar truss units having a plurality of struts joined at nodes. A first portion of struts that comprise the space truss have a physical property that is different from a second portion of the struts that comprise the space truss. The first portion of struts that comprise the space truss may have: a deformation strength; a defined length; a diameter; a differential diameter along its length; a density; a porosity; or any combination of these physical properties; that is different from the second portion of the struts that comprise the space truss. In an embodiment, the space truss includes one or more central struts extending from the first bone contact surface to the second bone contact surface, wherein the central struts have a deformation strength that is greater than or less than the surrounding struts. In an embodiment, the space truss comprises one or more longitudinal struts extending parallel to the first bone contact surface and/or the second bone contact surface, wherein the longitudinal struts have a deformation strength that is greater than or less than the surrounding struts. The diameter of the first portion of the struts may be greater than a diameter of the second portion of the struts. The material used to form the first portion of struts may be different from the material used to form the second portion of struts.
Advantages of the present invention will become apparent to those skilled in the art with the benefit of the following detailed description of embodiments and upon reference to the accompanying drawings in which:
While the invention is susceptible to various modifications and alternative forms, specific embodiments thereof are shown by way of example in the drawings and will herein be described in detail. It should be understood, however, that the drawings and detailed description thereto are not intended to limit the invention to the particular form disclosed, but on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present invention as defined by the appended claims. Note, the headings are for organizational purposes only and are not meant to be used to limit or interpret the description or claims.
As used herein a “truss structure” is a structure having one or more elongate struts connected at joints referred to as nodes. Trusses may include variants of a pratt truss, king post truss, queen post truss, town's lattice truss, planar truss, space truss, and/or a vierendeel truss (other trusses may also be used). A “truss unit” is a structure having a perimeter defined by three or more elongate struts.”
As used herein a “planar truss” is a truss structure where all of the struts and nodes lie substantially within a single two-dimensional plane. A planar truss, for example, may include one or more “truss units” where each of the struts is a substantially straight member such that the entirety of the struts and the nodes of the one or more truss units lie in substantially the same plane. A truss unit where each of the struts is a substantially straight strut and the entirety of the struts and the nodes of the truss unit lie in substantially the same plane is referred to as a “planar truss unit.”
As used herein a “space truss” is a truss having struts and nodes that are not substantially confined in a single two-dimensional plane. A space truss may include two or more planar trusses (e.g., planar truss units) wherein at least one of the two or more planar trusses lies in a plane that is not substantially parallel to a plane of at least one or more of the other two or more planar trusses. A space truss, for example, may include two planar truss units adjacent to one another (e.g., sharing a common strut) wherein each of the planar truss units lie in separate planes that are angled with respect to one another (e.g., not parallel to one another).
As used herein a “triangular truss” is a structure having one or more triangular units that are formed by three straight struts connected at joints referred to as nodes. For example, a triangular truss may include three straight elongate strut members that are coupled to one another at three nodes to from a triangular shaped truss. As used herein a “planar triangular truss” is a triangular truss structure where all of the struts and nodes lie substantially within a single two-dimensional plane. Each triangular unit may be referred to as a “triangular truss unit.” A triangular truss unit where each of the struts is a substantially straight member such that the entirety of the struts and the nodes of the triangular truss units lie in substantially the same plane is referred to as a “planar triangular truss unit.” As used herein a “triangular space truss” is a space truss including one or more triangular truss units.
In various embodiments, the trusses 102 of the web structure may include one or more planar truss units (e.g., planar triangular truss units) constructed with straight or curved/arched members (e.g., struts) connected at various nodes. In some embodiments, the trusses 102 may be micro-trusses. A “micro-truss” is a truss having dimensions sufficiently small enough such that a plurality of micro-trusses can be assembled or otherwise coupled to one another to form a web structure having a small enough overall dimension (e.g., height, length and width) such that substantially all of the web structure can be inserted into an implant location (e.g., between two vertebra). Such a web structure and its micro-trusses can thus be employed to receive and distribute throughout the web structure loading forces of the surrounding tissue (e.g., vertebra, bone, or the like). In one embodiment, the diameters of the struts forming the micro-truss may be between about 0.25 millimeters (mm) and 5 mm in diameter (e.g., a diameter of about 0.25 mm, 0.5 mm, 0.6 mm, 0.7 mm, 0.8 mm, 0.9 mm, 1 mm, 2 mm, 3 mm, 4 mm, or 5 mm). In one embodiment, a micro-truss may have an overall length or width of less than about 1 inch (e.g., a length less than about 0.9 in, 0.8 in, 0.7 in, 0.6 in, 0.5 in, 0.4 in, 0.3 in, 0.2 in, 0.1 in).
As depicted, for example, in
In one embodiment, web structure of the implant 100 may include an internal web structure that is at least partially enclosed by an external truss structure. For example, in one embodiment, web structure 100 may include an internal web structure that includes a space truss having at least a portion of the space truss surrounded by an external truss structure that includes one or more planar trusses formed with a plurality of planar truss units that lie substantially in a single plane.
In one embodiment, external truss structure 105 includes a plurality of planar trusses that are coupled about an exterior, interior or other portion of the implant. For example, in the illustrated embodiment, the external truss structure 105 includes a series of planar trusses 107a,b that are coupled to one another. Planar truss 107a is denoted by a dashed line [- - - - -], planar truss 107b is denoted by dotted-dashed line [- ⋅ - ⋅ -]. Each planar truss is formed from a plurality of planar truss units (e.g., triangular planar truss units). As depicted, planar truss 107a includes four triangular planar truss units 108a,b,c,d having a common vertex 110 and arranged to form a generally rectangular structure that lies in a single common plane. In other words, the four triangular planar truss units are arranged to form a substantially rectangular structure having “X” shaped struts that extend from one corner of the rectangular structure to the opposite corner of the rectangular structure. As depicted, the substantially rectangular structure may include a trapezoidal shape. As described in more detail below, the trapezoidal shape may be conducive to providing an implant including lordosis. Lordosis may include an angled orientation of surfaces (e.g., top and bottom) of an implant that provides for differences in thickness in anterior and posterior regions of the implant such that the implant is conducive for supporting the curvature of a vertebral column.
In one embodiment, the planar trusses that form the external truss are coupled to one another, and are aligned along at least one axis. For example, in
In one embodiment, the external truss portion may encompass the sides, top, and/or bottom of the implant. For example, in one embodiment, the external truss portion may include a top region, side regions, and/or a bottom region.
In some embodiments, implant 100 may be formed from a biocompatible material such as a titanium alloy (e.g., γTitanium Aluminides), cobalt, chromium, stainless steel, Polyetheretherketone (PEEK), ceramics, etc. Other materials are also contemplated. In some embodiments, implant 100 may be made through a rapid prototyping process (e.g., electron beam melting (EBM) process) as further described below. Other processes are also possible (e.g., injection molding, casting, sintering, selective laser sintering (SLS), Direct Metal Laser Sintering (DMLS), etc). SLS may include laser-sintering of high-performance polymers such as that provided by EOS of North America, Inc., headquartered in Novi, Michigan, U.S.A. High-performance polymers may include various forms of PEEK (e.g., HP3 having a tensile strength of up to about 95 mega Pascal (MPa) and a Young's modulus of up to about 4400 MPa and continuous operating temperature between about 180° C. (356° F.) and 260° C. (500° F.)). Other materials may include PA 12 and PA 11 provided by EOS of North America, Inc.
As described above, in some embodiments the web structure may be formed from a plurality of triangular planar truss units. In some embodiments, the planar truss units may be coupled to each other to define polyhedrons that define the internal web structure. Examples of polyhedron structures that may be created by joining planar truss units include, but are not limited to, tetrahedrons, pentahedrons, hexahedrons, heptahedrons, pyramids, octahedrons, dodecahedrons, icosahedrons, and spherical fullerenes. In some embodiments, such as those described above, the space truss of the web structure may connect multiple midpoints of tetrahedron building blocks and include a regular pattern of tetrahedron blocks arranged adjacent one another. In some embodiments, the web structure may not include a pattern of geometrical building blocks. For example,
As seen in
As shown in
As depicted in
In some embodiments, the implant may not include lordosis. For example,
In some embodiments, the web structure of an implant may distribute forces throughout the implant when implanted. For example, the connecting struts of the web structure may extend throughout the core of an implant, and the interconnectivity of struts may disperse the stress of compressive forces throughout implant to reduce the potential of stress risers (the distribution of forces throughout the implant may prevent concentration of stress on one or more portions of the vertebrae that may otherwise result in damage to the vertebrae).
In some embodiments, the web structure of an implant (e.g., the external and internal struts of the implant) may also provide surface area for bone graft fusion. For example, the web structure extending throughout an implant may add additional surface areas (e.g., on the surface of the struts making up the implant) to fuse to the bone graft material and prevent bone graft material from loosening or migrating from the implant. In some embodiments, the web structure may also support bone in-growth. For example, when implanted, adjacent bone (e.g., adjacent vertebrae if the implant is used as a spinal implant) may grow over at least a portion of struts of the implant. The bone growth and engagement between the bone growth and the implant may further stabilize the implant. In some embodiments, the surfaces of the implant may be formed with a rough surface to assist in bone in-growth adhesion.
In some embodiments, struts may have a diameter approximately in a range of about 0.025 to 5 millimeters (mm) (e.g., 1.0 mm, 1.5 mm, 3 mm, etc). Other diameters are also contemplated (e.g., greater than 5 mm). In some embodiments, the struts may have a length approximately in a range of 0.5 to 20 mm (e.g., depending on the implant size needed to, for example, fit a gap between vertebral endplates). As another example, struts may have a length approximately in a range of 30-40 mm for a hip implant. In some embodiments, the reduced strut size of the web structure may allow the open cells in implant 100 to facilitate bone growth (e.g., bone may grow through the open cells once implant 100 is implanted in the body). Average subsidence for implants may be approximately 1.5 mm within the first 3 weeks post op (other subsidence is also possible (e.g., approximately between 0.5 to 2.5 mm)). A strut size that approximately matches the subsidence (e.g., a strut size of approximately 1.5 mm in diameter and a subsidence of approximately 1.5 mm) may result in a net 0 impedance (e.g., the bone growth growing around the struts) after the implant has settled in the implanted position. The net 0 impedance throughout the entire surface area of the implant/vertebrae endplate interface may result in a larger fusion column of bone that may result in more stable fusion. Other fusion column sizes are also contemplated. The configuration of the implant may redistribute the metal throughout the implant. In some embodiments, a rim may not be included on the implant (in some embodiments, a rim may be included). The resulting bone growth (e.g., spinal column) may grow through the implant.
In some embodiments, greater than 50% of the interior volume of an implant may be open. In some embodiments, greater than 60%, greater than 70%, and/or greater than 80% of implant 100 may be open (e.g., 95%). In some embodiments, the open volume may be filled with bone growth material. For example, cancellous bone may be packed into an open/internal region of implant.
In some embodiments, at least a portion of the surfaces of the implant may be coated/treated with a material intend to promote bone growth and/or bone adhesion and/or an anitmicrobial agent to prevent infections. For example, in some embodiments, the surface of the struts may be coated with a biologic and/or a bone growth factor. In some embodiments, a biologic may include a coating, such as hydroxyapatite, bone morphogenetic protein (BMP), insulinlike growth factors I and II, transforming growth factor-beta, acidic and basic fibroblast growth factor, platelet-derived growth factor, and/or similar bone growth stimulant that facilitates good biological fixation between the bone growth and a surface of the implant. In some embodiments, a bone growth factor may include a naturally occurring substance capable of stimulating cellular growth, proliferation and cellular differentiation (e.g., a protein or steroid hormone). In some embodiments, the surface of the implant (e.g., the struts, the external truss structure, etc.) may be coated with collagen.
In some embodiments, a biologic and/or growth factor may be secured to a central region of an implant. For example, in some embodiments, a biologic or growth factor may be provided on at least a portion of a strut that extends through central portion 501a and/or 501b of implant 100, see
As the implant settles into the implant site, subsidence may place additional pressure on the bone graft material (which may already be under compressive forces in the implant) and act to push the bone graft material toward the sides of the implant (according to Boussinesq's theory of adjacent material, when a force is applied to a member that is adjacent to other materials (such as sand, dirt, or bone graft material) the force against the member creates a zone of increased pressure (e.g., 60 degrees) in the adjacent material). Struts of the implant may resist bone graft material protrusion from the sides of the web structure and may increase the pressure of the bone graft material. Bone graft material may need to be implanted in a higher-pressure environment to create an environment conducive to strong bone growth (e.g., according to Wolf's law that bone in a healthy person or animal will adapt to the loads it is placed under). The web structure may thus increase the chance of stronger fusion.
Web structures formed from other truss configurations are also contemplated. For example, the trusses may include a series of packing triangles, a two-web truss, a three-web truss, etc. Further, the web structure for an implant may include one or more trusses as described in U.S. Pat. No. 6,931,812 titled “Web Structure and Method for Making the Same”, which issued Aug. 23, 2005, which is hereby incorporated by reference in its entirety as though fully and completely set forth herein.
At 1001, a three-dimensional model of an implant is generated and stored in a storage medium accessible to a controller operable to control the implant production process. At 1003, a layer of material (e.g., a powder, liquid, etc.) is applied to a support. In some embodiments, the powder may include γTiAl (γTitanium Aluminides) which may be a high strength/low weight material. Other materials may also be used. The powder may be formed using a gas atomization process and may include granules with diameters approximately in a range of 20 to 200 micrometers (μm) (e.g., approximately 80 μm). The powder may be delivered to the support through a distributer (e.g., delivered from a storage container). The distributer and/or the support may move during distribution to apply a layer (e.g., of powder) to the support. In some embodiments, the layer may be approximately a uniform thickness (e.g., with an average thickness of 20 to 200 micrometers (μm)). In some embodiments, the distributer and support may not move (e.g., the material may be sprayed onto the support). At 1005, the controller moves an electron beam relative to the material layer. In some embodiments, the electron beam generator may be moved, and in some embodiments the support may be moved. If the material is γTiAl, a melting temperature approximately in a range of 1200 to 1800 degrees Celsius (e.g., 1500 degrees Celsius) may be obtained between the electron beam and the material. At 1007, between each electron beam pass, additional material may be applied by the distributer. At 1009, the unmelted material is removed and the implantcooled (e.g., using a cool inert gas). In some embodiments, the edges of the implant may be smoothed to remove rough edges (e.g., using a diamond sander). In some embodiments, the implant may include rough edges to increase friction between the implant and the surrounding bone to increase adhesion of the implant to the bone.
Other methods of making an implant are also contemplated. For example, an implant may be cast or injection molded. In some embodiments, multiple parts may be cast or injection molded and joined together (e.g., through welding, melting, etc). In some embodiments, individual struts forming the implant may be generated separately (e.g., by casting, injection molding, etc.) and welded together to form the implant. In some embodiments, multiple implants of different sizes may be constructed and delivered in a kit. A medical health professional may choose an implant (e.g., according to a needed size) during the surgery. In some embodiments, multiple implants may be used at the implant site.
Specialized tools may be used to insert the implants described herein. Examples of tools that may be used are described in U.S. Published Patent Applications Nos.: 2010/0161061; 2011/0196495; 20110313532; and 2013/0030529, each of which is incorporated herein by reference.
In some embodiments, the implant may be customized. For example, three dimensional measurements and/or shape of the implant may be used to construct an implant that distributes the web structure throughout a three-dimensional shape design.
In some embodiments, a truss/web structure may be disposed on at least a portion of an implant to facilitate coupling of the implant to an adjacent structure. For example, where an implant is implanted adjacent a bony structure, one or more truss structures may be disposed on and/or extend from a surface (e.g., an interface plate) of the implant that is intended to contact, and at least partially adhere to, the bony structure during use. In some embodiments, one or more truss structures may be disposed on a contact surface of the implant to facilitate bone growth that enhances coupling of the implant to the bony structure. For example, a truss structure may include one or more struts that extend from the contact surface to define an open space for bone growth therethrough, thereby enabling bone through growth to interlock the bone structure and the truss structure with one another to couple the implant to the bony structure at or near the contact face. Such interlocking bone through growth may inhibit movement between the implant and the bony structure which could otherwise lead to loosening, migration, subsidence, or dislodging of the implant from the intended position. Similar techniques may be employed with various types of implants, including those intended to interface with tissue and/or bone structures. For example, a truss structure may be employed on a contact surface of knee implants, in a corpectomy device, in a hip replacement, in a knee replacement, in a long bone reconstruction scaffold, or in a cranio-maxifacial implant hip implants, jaw implant, an implant for long bone reconstruction, foot and ankle implants, shoulder implants or other joint replacement implants or the like to enhance adherence of the implant to the adjacent bony structure or tissue. Examples of truss structures, and other structures, that may extend from the surface of an implant to facilitate coupling of the implant to an adjacent structure are described in U.S. Published Patent Application No. 2011/0313532, which is incorporated herein by reference.
While implants described herein are depicted as being composed of substantially straight struts, it should be understood that the struts can be non-linear, including, but not limited to curved, arcuate and arch shaped. Examples of implants having non-linear struts are described in U.S. patent application Ser. No. 13/668,968, which is incorporated herein by reference.
It is known that osteoblasts under an appropriate load produce bone morphogenetic protein (“BMP”). BMPs are a group of growth factors also known as cytokines and as metabologens. BMPs act as morphogenetic signals that signal the formation of bone (i.e., an osteogenetic response). Thus, by increasing the production of one or more BMPs the osteogentic response to an implant is increased, creating an implant that is integrated into the newly formed bone.
A web structure that includes a plurality of joined truss units exhibits a number of deformations in response to loading.
In an embodiment, an implant for interfacing with a bone structure includes a web structure comprising a plurality of struts joined at nodes. The web structure is configured to interface with human bone tissue. In one embodiment, a diameter and/or length of the struts are predetermined such that when the web structure is in contact with the bone structure, BMP production from osteoblasts adhering to the implant surface is achieved. In one embodiment, the diameter and/or length of the struts is predetermined so that at least a portion of the struts create a microstrain in the adhered osteoblasts of between about 1 and 5000 microstrain, 500με and about 2000με or between about 1000με and about 1500με. In an embodiment, the diameter and/or length of the struts is predetermined so that at least a portion of the struts create a change in length of the adhered osteoblasts of between about 0.05% and about 0.2% or between about 0.1% and about 0.15%.
An implant may be prepared having struts of a length of between about 1 to 100 mm. The diameter of the struts may be set such that the strut undergoes a change of length of between about 0.05% and 0.2% when the web structure is in contact with the bone structure. In some embodiments, the diameter of the struts is predetermined such that the strut undergoes a change of length of between about 0.000125% and 0.0005% or between about 0.00025% and 0.000375%.
Any implant described herein may be modified so that at least a portion of the struts that form the web structure produce the appropriate microstrain/lengthening of adhered osteoblasts. In some embodiments, most, if not all, of the struts that form the web structure of an implant may be ‘programmed’ (or designed) to stimulate BMP production. In other embodiments, some struts may be programmed/designed for BMP production, while other struts have different physical properties than the programmed struts.
An implant may be optimized to distribute stresses encountered by the implant. Most implants used for bone repair are placed in locations that apply non-uniform stress to the implant. The non-uniform stress creates different forces across the implant. If an implant is designed to withstand a certain homogenous force, the implant may fail when subjected to non-uniform stress. In a non-uniform stress situation, some of the stress on the implant may be sufficient to deform the implant. It is desirable to have an implant that is customized to the expected non-uniform stress that will be encountered in the bone structure being repaired.
In an embodiment, an implant for interfacing with a bone structure, includes a web structure having a plurality of struts joined at nodes. The web structure is configured to interface with human bone tissue, and has a first bone contact surface and a second bone contact surface. A first portion of struts that are part of the space truss have a physical property that is different from a second portion of the struts that are a part of the space truss. In this manner an implant may be created which optimizes the stresses encountered by the implant to help inhibit failure of the implant.
In one embodiment, the first portion of struts that are part of the space truss have a deformation strength that is different from a second portion of the struts that are a part of the space truss. The space truss may include one or more central struts extending from the first bone contact surface to the second bone contact surface. The central struts may have a deformation strength that is greater than or less than the surrounding struts, depending on the location of the implant. The space truss may include one or more longitudinal struts extending parallel to the first bone contact surface and/or the second bone contact surface, wherein the longitudinal struts have a deformation strength that is greater than or less than the surrounding struts.
The physical properties of the struts of the implant may be varied such that the diameter of the first portion of the struts is greater than a diameter of the second portion of the struts. In some embodiments, the first portion of struts are formed from a material that is different from the material used to form the second portion of struts. In some embodiments, the first portion of struts have a diameter that is different from the diameter of the second portion of struts. In some embodiments, the first portion of struts have a density that is different from the density of the second portion of struts. In some embodiments, the first portion of struts have a porosity that is different from the porosity of the second portion of struts. Any combination of these different physical properties may be present in an implant to help optimize the distribution of stress throughout the implant.
As noted above, it is desirable to provide an improved intramedullary implant that more evenly distributes stress through the bone, leading to less loosening of the implant caused by bone remodeling due to stress shielding. In an embodiment, an intramedullary implant is configured to distribute load in a uniform, or at least a more natural way, so that bone resorption was limited and remained relatively stable. The implant is designed so that stress concentrations are minimized, leading to less dynamic boney changes resulting from regional stress.
A space truss 1230 coupled to the outer contact faces of body 1210. During use, space truss 1230 is at least partially disposed inside medullary cavity of bone 1220. The space truss is positioned between the intramedullary body 1215 of the implant and the medullary cavity. In an embodiment, the space truss comprises two or more planar truss units having a plurality of struts joined at nodes. A diameter and/or length of the struts and/or density of the space truss are predetermined such that when the space truss is in contact with the bone at least a portion of strain on the intramedullary rod is distributed through the web structure to the bone. In
The space truss is designed to optimize strain transfer along the whole length of the bone-implant interface. In this manner, stress shielding may be avoided, leading to a lower chance of bone remodeling. In addition to the design of the space truss, the implant body may also be optimized to distribute stress. Features that may be altered during optimization include, but are not limited to, length of the solid portion of the implant, angle and slope of the tapered section, length of the space truss portion.
In intramedullary implants, the stress on the bone changes from the stresses normally encountered on healthy bone. For example, increased stress (compared to normal stress in healthy bone) is placed on the distal portion of the bone (i.e., the portion of the bone furthest from the entry point of the implant into the bone). The increased stress on the distal portion of the bone creates reduced stress (compared to normal stress on healthy bone) on the proximal portion of the bone. This change in stress along the bone leads to adaptive bone remodeling. The reduced load on the proximal portion leads to osteolysis, which, in turn can lead to losing or failure of the implant. The space truss is therefore designed to transfer the increased stress at the distal portion of the implant to the proximal portion of the implant, creating a more even distribution of the stress throughout the implant site. This can be accomplished by changing the density of the struts (i.e., the number of structs per volume), the thickness of the struts, the direction of the struts, or any combination thereof. The implant can be customized to the specific bone by appropriately modifying at least one of these physical properties of the space truss.
In one embodiment, the intramedullary implant is used for attachment of a prosthetic device. The implant may include an extra-corporal component 1240 to have a mechanism which can receive a corresponding connector from a prosthetic device. An exemplary intermedullary system for attachment of a prosthetic device is the OPRA implant system.
Such a system may be enhanced by adding a space truss to the exterior of the fixture portion of the implant, between the fixture and the bone tissue.
In this patent, certain U.S. patents, U.S. patent applications, and other materials (e.g., articles) have been incorporated by reference. The text of such U.S. patents, U.S. patent applications, and other materials is, however, only incorporated by reference to the extent that no conflict exists between such text and the other statements and drawings set forth herein. In the event of such conflict, then any such conflicting text in such incorporated by reference U.S. patents, U.S. patent applications, and other materials is specifically not incorporated by reference in this patent.
In accordance with the above descriptions, in various embodiments, an implant may include a web structure. The web structure for the implant may include a micro truss design. In some embodiments, the micro truss design may include a web structure with multiple struts. Other web structures are also contemplated. The web structure may extend throughout the implant (including a central portion of the implant). The web structure may thus reinforce the implant along multiple planes (including internal implant load bearing) and provide increased area for bone graft fusion. The web structure may be used in implants such as spinal implants, corpectomy devices, hip replacements, knee replacements, long bone reconstruction scaffolding, and cranio-maxillofacial implants foot and ankle, hand and wrist, shoulder and elbow (large joint, small joint, extremities). Other implant uses are also contemplated. In some embodiments, the web structure for the implant may include one or more geometric objects (e.g., polyhedrons). In some embodiments, the web structure may not include a pattern of geometrical building blocks (e.g., an irregular pattern of struts may be used in the implant). In some embodiments, the web structure may include a triangulated web structure including two or more tetrahedrons. A tetrahedron may include four triangular faces in which three of the four triangles meet at each vertex. The web structure may further include two tetrahedrons placed together at two adjacent faces to form a web structure with a hexahedron-shaped frame (including six faces). In some embodiments, multiple hexahedron-shaped web structures may be arranged in a side-by-side manner. The web structures may connect directly through side vertices (e.g., two or more hexahedron-shaped web structures may share a vertex). In some embodiments, the web structure may be angled to provide lordosis to the implant.
Further modifications and alternative embodiments of various aspects of the invention may be apparent to those skilled in the art in view of this description. For example, although in certain embodiments, struts have been described and depicts as substantially straight elongated members, struts may also include elongated members curved/arched along at least a portion of their length. Accordingly, this description is to be construed as illustrative only and is for the purpose of teaching those skilled in the art the general manner of carrying out the invention. It is to be understood that the forms of the invention shown and described herein are to be taken as embodiments. Elements and materials may be substituted for those illustrated and described herein, parts and processes may be reversed, and certain features of the invention may be utilized independently, all as would be apparent to one skilled in the art after having the benefit of this description of the invention. Changes may be made in the elements described herein without departing from the spirit and scope of the invention as described in the following claims. Furthermore, it is noted that the word “may” is used throughout this application in a permissive sense (i.e., having the potential to, being able to), not a mandatory sense (i.e., must). The term “include”, and derivations thereof, mean “including, but not limited to”. As used in this specification and the claims, the singular forms “a”, “an” and “the” include plural referents unless the content clearly indicates otherwise. Thus, for example, reference to “a strut” includes a combination of two or more struts. The term “coupled” means “directly or indirectly connected”.
Number | Name | Date | Kind |
---|---|---|---|
3840904 | Tronzo | Oct 1974 | A |
3867728 | Stubstad et al. | Feb 1975 | A |
4129903 | Huggler | Dec 1978 | A |
4686970 | Dove et al. | Aug 1987 | A |
4820305 | Harms et al. | Apr 1989 | A |
4863474 | Brown et al. | Sep 1989 | A |
4904261 | Dove et al. | Feb 1990 | A |
4938771 | Vecsei et al. | Jul 1990 | A |
5030233 | Ducheyne | Jul 1991 | A |
5108435 | Gustavson et al. | Apr 1992 | A |
5147402 | Bohler et al. | Sep 1992 | A |
5201768 | Caspari et al. | Apr 1993 | A |
5282861 | Kaplan | Feb 1994 | A |
5306149 | Schmid et al. | Apr 1994 | A |
5336266 | Caspari et al. | Aug 1994 | A |
5433750 | Gradinger et al. | Jul 1995 | A |
5571185 | Schug | Nov 1996 | A |
5609635 | Michelson | Mar 1997 | A |
5609637 | Biedermann et al. | Mar 1997 | A |
5676700 | Black et al. | Oct 1997 | A |
5702449 | McKay | Dec 1997 | A |
5702451 | Biedermann et al. | Dec 1997 | A |
5879385 | Crockard et al. | Mar 1999 | A |
5897556 | Drewry et al. | Apr 1999 | A |
5954504 | Misch et al. | Sep 1999 | A |
5989290 | Biedermann et al. | Nov 1999 | A |
6010502 | Bagby | Jan 2000 | A |
6090732 | Ita et al. | Jul 2000 | A |
6143032 | Schafer et al. | Nov 2000 | A |
6149689 | Grundei et al. | Nov 2000 | A |
6206924 | Timm | Mar 2001 | B1 |
6245108 | Biscup | Jun 2001 | B1 |
6245110 | Grundei et al. | Jun 2001 | B1 |
6264695 | Stoy | Jul 2001 | B1 |
6280478 | Richter et al. | Aug 2001 | B1 |
6290726 | Pope et al. | Sep 2001 | B1 |
6379385 | Kalas et al. | Apr 2002 | B1 |
6464727 | Sharkey et al. | Oct 2002 | B1 |
6520997 | Pekkarinen et al. | Feb 2003 | B1 |
6585770 | White et al. | Jul 2003 | B1 |
6660041 | Grundei | Dec 2003 | B1 |
6712852 | Chung et al. | Mar 2004 | B1 |
6730252 | Teoh et al. | May 2004 | B1 |
D493533 | Blain | Jul 2004 | S |
6761738 | Boyd | Jul 2004 | B1 |
6866682 | An et al. | Mar 2005 | B1 |
6881228 | Zdeblick et al. | Apr 2005 | B2 |
6931812 | Lipscomb | Aug 2005 | B1 |
6972019 | Michelson | Dec 2005 | B2 |
7156874 | Paponneau et al. | Jan 2007 | B2 |
7163560 | Mason | Jan 2007 | B2 |
7163561 | Michelson | Jan 2007 | B2 |
7208222 | Rolfe et al. | Apr 2007 | B2 |
7291149 | Michelson | Nov 2007 | B1 |
7537616 | Branch et al. | May 2009 | B1 |
7572293 | Rhodes et al. | Aug 2009 | B2 |
7578850 | Kuczynski et al. | Aug 2009 | B2 |
7621950 | Globerman et al. | Nov 2009 | B1 |
7846296 | Oglaza et al. | Dec 2010 | B2 |
8062365 | Schwab | Nov 2011 | B2 |
8292967 | Brown et al. | Oct 2012 | B2 |
8430930 | Hunt | Apr 2013 | B2 |
8906074 | Kang | Dec 2014 | B2 |
8998990 | Bertagnoli et al. | Apr 2015 | B2 |
9271845 | Hunt | Mar 2016 | B2 |
9421108 | Hunt | Aug 2016 | B2 |
9545317 | Hunt | Jan 2017 | B2 |
9549823 | Hunt | Jan 2017 | B2 |
9572669 | Hunt | Feb 2017 | B2 |
9636226 | Hunt | May 2017 | B2 |
9757235 | Hunt | Sep 2017 | B2 |
9968463 | Liu | May 2018 | B2 |
9987137 | Hunt | Jun 2018 | B2 |
9999516 | Hunt | Jun 2018 | B2 |
20020169066 | Cassidy et al. | Nov 2002 | A1 |
20020183858 | Contiliano et al. | Dec 2002 | A1 |
20030078660 | Clifford et al. | Apr 2003 | A1 |
20040082999 | Mathys et al. | Apr 2004 | A1 |
20040121451 | Mortiz et al. | Jun 2004 | A1 |
20040236336 | Foerster | Nov 2004 | A1 |
20040252382 | Nagata | Dec 2004 | A1 |
20050004572 | Bidermann et al. | Jan 2005 | A1 |
20050015154 | Lindsey | Jan 2005 | A1 |
20050033425 | Schwab | Feb 2005 | A1 |
20050090900 | Nordquist | Apr 2005 | A1 |
20050129726 | Liebschner | Jun 2005 | A1 |
20050143827 | Globerman et al. | Jun 2005 | A1 |
20050171613 | Sartorius et al. | Aug 2005 | A1 |
20050222683 | Berry | Oct 2005 | A1 |
20060074488 | Abdou | Apr 2006 | A1 |
20060106461 | Embry et al. | May 2006 | A1 |
20060147332 | Jones et al. | Jul 2006 | A1 |
20060200062 | Saadat | Sep 2006 | A1 |
20060241776 | Brown et al. | Oct 2006 | A1 |
20070027544 | McCord et al. | Feb 2007 | A1 |
20070032876 | Clark | Feb 2007 | A1 |
20070040478 | Tofail et al. | Feb 2007 | A1 |
20070055376 | Michelson | Mar 2007 | A1 |
20070083268 | Teoh et al. | Apr 2007 | A1 |
20070106383 | Abdou | May 2007 | A1 |
20070129806 | Harms et al. | Jun 2007 | A1 |
20070179610 | Biedermann et al. | Aug 2007 | A1 |
20070191834 | Bruneau et al. | Aug 2007 | A1 |
20070233248 | Schwab et al. | Oct 2007 | A1 |
20070255420 | Johnson et al. | Nov 2007 | A1 |
20070255422 | Weir et al. | Nov 2007 | A1 |
20070270956 | Heinz | Nov 2007 | A1 |
20080014457 | Gennaro et al. | Jan 2008 | A1 |
20080021461 | Barker et al. | Jan 2008 | A1 |
20080039948 | Biedermann et al. | Feb 2008 | A1 |
20080071356 | Greenhalgh et al. | Mar 2008 | A1 |
20080075752 | Ratner et al. | Mar 2008 | A1 |
20080154314 | McDevitt | Jun 2008 | A1 |
20080221594 | Hamman et al. | Sep 2008 | A1 |
20090054987 | Chin | Feb 2009 | A1 |
20090076508 | Weinans et al. | Mar 2009 | A1 |
20090138015 | Conner et al. | May 2009 | A1 |
20090149947 | Frohwitter | Jun 2009 | A1 |
20090149956 | Greenhalgh et al. | Jun 2009 | A1 |
20090182336 | Brenzel et al. | Jul 2009 | A1 |
20090222098 | Trieu et al. | Sep 2009 | A1 |
20090228112 | Clark et al. | Sep 2009 | A1 |
20090276048 | Chirico et al. | Nov 2009 | A1 |
20090317447 | Hsiao et al. | Dec 2009 | A1 |
20090326657 | Grinberg | Dec 2009 | A1 |
20100094292 | Parrott | Apr 2010 | A1 |
20100106194 | Bonutti | Apr 2010 | A1 |
20100161061 | Hunt | Jun 2010 | A1 |
20100174377 | Heuer | Jul 2010 | A1 |
20100174380 | Lewis | Jul 2010 | A1 |
20100179667 | Day et al. | Jul 2010 | A1 |
20100228355 | Linares | Sep 2010 | A1 |
20100298950 | McDonnel et al. | Nov 2010 | A1 |
20110022180 | Melkent et al. | Jan 2011 | A1 |
20110035020 | Laughner et al. | Feb 2011 | A1 |
20110076316 | Sivananthan et al. | Mar 2011 | A1 |
20110118852 | Evans | May 2011 | A1 |
20110125284 | Gabbrielli et al. | May 2011 | A1 |
20110196495 | Hunt | Aug 2011 | A1 |
20110218585 | Krinke | Sep 2011 | A1 |
20110251690 | Berger | Oct 2011 | A1 |
20110264229 | Donner | Oct 2011 | A1 |
20110307073 | Teoh et al. | Dec 2011 | A1 |
20110313532 | Hunt | Dec 2011 | A1 |
20120290089 | Melamed | Nov 2012 | A1 |
20130030529 | Hunt | Jan 2013 | A1 |
20130030540 | Leibinger | Jan 2013 | A1 |
20130123935 | Hunt | May 2013 | A1 |
20130158672 | Hunt | Jun 2013 | A1 |
20130184835 | Ferrari et al. | Jul 2013 | A1 |
20130218282 | Hunt | Aug 2013 | A1 |
20140121776 | Hunt | May 2014 | A1 |
20140277569 | Lange | Sep 2014 | A1 |
20140288649 | Hunt | Sep 2014 | A1 |
20140288650 | Hunt | Sep 2014 | A1 |
20150282933 | Hunt | Oct 2015 | A1 |
20150282945 | Hunt | Oct 2015 | A1 |
20150282946 | Hunt | Oct 2015 | A1 |
20160081807 | Estes et al. | Mar 2016 | A1 |
20160287389 | Hunt | Oct 2016 | A1 |
20160287404 | Hunt | Oct 2016 | A1 |
20160287405 | Hunt | Oct 2016 | A1 |
20160338842 | Adams | Nov 2016 | A1 |
20170157299 | Janko et al. | Jun 2017 | A1 |
20170216035 | Hunt | Aug 2017 | A1 |
20170319344 | Hunt | Nov 2017 | A1 |
20170360563 | Hunt | Dec 2017 | A1 |
20180064540 | Hunt | Mar 2018 | A1 |
20180085230 | Hunt | Mar 2018 | A1 |
20190060077 | Hunt | Feb 2019 | A1 |
20190151114 | Sack | May 2019 | A1 |
20200155326 | Hunt | May 2020 | A1 |
Number | Date | Country |
---|---|---|
201164511 | Dec 2008 | CN |
201200499 | Mar 2009 | CN |
19543530 | May 1997 | DE |
19721661 | Nov 1998 | DE |
10120330 | Nov 2002 | DE |
202006015414 | Nov 2006 | DE |
202006015415 | Nov 2006 | DE |
102006047663 | Apr 2008 | DE |
0396883 | Nov 1990 | EP |
0268115 | Jan 1991 | EP |
0489684 | Jun 1992 | EP |
0561263 | Sep 1993 | EP |
1925271 | May 2008 | EP |
52-148995 | Dec 1977 | JP |
HEI06-503990 | May 1994 | JP |
2002-536046 | Oct 2002 | JP |
2003-511198 | Mar 2003 | JP |
2007-167665 | Jul 2007 | JP |
2008-539817 | Nov 2008 | JP |
2009-006186 | Jan 2009 | JP |
2009112719 | May 2009 | JP |
2012520120 | Sep 2012 | JP |
2001028460 | Apr 2001 | WO |
02071986 | Sep 2002 | WO |
2005009729 | Feb 2005 | WO |
2007048817 | May 2007 | WO |
2008022206 | Feb 2008 | WO |
2008146141 | Dec 2008 | WO |
2009144434 | Dec 2009 | WO |
2010080511 | Jul 2010 | WO |
2012010327 | Jan 2012 | WO |
2013006778 | Jan 2013 | WO |
Entry |
---|
International Search Report and Written Opinion for PCT/US2021/040939 issued Nov. 4, 2021. |
Advisory Action for U.S. Appl. No. 15/721,940 issued Mar. 13, 2020. |
Office Action for U.S. Appl. No. 15/721,940 issued Jun. 2, 2020. |
Office Action for U.S. Appl. No. 12/818,508 issued Feb. 4, 2013. |
Final Office Action for U.S. Appl. No. 12/818,508 issued Aug. 15, 2013. |
Office Action for U.S. Appl. No. 12/818,508 issued May 22, 2015. |
Final Office Action for U.S. Appl. No. 12/818,508 issued Nov. 20, 2015. |
Office Action for U.S. Appl. No. 12/818,508 issued Dec. 2, 2016. |
EPO International Search Report and Written Opinion for PCT/US2011/040117 mailed Aug. 12, 2011. |
International Preliminary Report on Patentability for PCT/US2011/040117 dated Dec. 19, 2012. |
Office Action for U.S. Appl. No. 13/805,231 issued Aug. 20, 2015. |
Final Office Action for U.S. Appl. No. 13/805,231 issued Dec. 11, 2015. |
Office Action for U.S. Appl. No. 13/805,231 issued Oct. 12, 2016. |
Final Office Action for U.S. Appl. No. 13/805,231 issued Apr. 25, 2017. |
Office Action for U.S. Appl. No. 13/805,231 issued Dec. 18, 2017. |
Australian Examination Report for AU Application No. 2011267941 dated Jan. 16, 2014. |
Canadian Examination Report for Canadian Patent Application No. 2,803,015 dated Jun. 15, 2017. |
Canadian Examination Report for Canadian Patent Application No. 2,803,015 dated Feb. 9, 2018. |
Canadian Examination Report for Canadian Patent Application No. 2,803,015 dated Dec. 5, 2019. |
Canadian Examination Report for Canadian Patent Application No. 2,803,015 dated Dec. 30, 2020. |
European Examination Report for EP Application No. 11726306.1 dated Jan. 7, 2016. |
European Examination Report for EP Application No. 11726306.1 dated Nov. 13, 2017. |
Japanese Examination Report for JP Application No. 2013-515407 dated Feb. 24, 2015. |
Japanese Examination Report for JP Application No. 2013-515407 dated Nov. 24, 2015. |
Office Action for U.S. Appl. No. 13/194,561 issued Mar. 19, 2013. |
Final Office Action for U.S. Appl. No. 13/194,561 issued Sep. 26, 2013. |
Office Action for U.S. Appl. No. 13/194,561 issued Jan. 20, 2015. |
International Search Report and Written Opinion for PCT/US2012/048300 May 7, 2013. |
International Preliminary Report on Patentability for PCT/US2012/048300 Feb. 4, 2014. |
Japanese Examination Report for JP Application No. 2014-523976 dated May 24, 2016. |
International Search Report and Written Opinion for PCT/US2012/045717 issued Jan. 30, 2013. |
International Preliminary Report on Patentability for PCT/US2012/045717 dated Jan. 7, 2014. |
Office Action for U.S. Appl. No. 13/668,968 issued Aug. 18, 2014. |
Office Action for U.S. Appl. No. 13/668,968 issued Jan. 7, 2015. |
Office Action for U.S. Appl. No. 13/668,968 issued Jun. 29, 2015. |
Office Action for U.S. Appl. No. 13/668,968 issued Apr. 14, 2016. |
Final Office Action for U.S. Appl. No. 13/668,968 issued Nov. 16, 2016. |
International Search Report and Written Opinion for PCT/US2012/063600 issued Jan. 31, 2013. |
International Preliminary Report on Patentability for PCT/US2012/063600 issued May 6, 2014. |
Australian Examination Report for AU Application No. 2012332092 dated Feb. 14, 2017. |
Australian Examination Report for AU Application No. 2012332092 dated Dec. 19, 2017. |
Australian Examination Report for AU Application No. 2012332092 dated Feb. 9, 2018. |
Canadian Examination Report for Canadian Patent Application No. 2,854,021 dated Jul. 26, 2018. |
Supplemental European Search Report for EP Application No. 12846553.1 issued May 20, 2015. |
European Office Action for EP Application No. 12846553.1 issued Mar. 17, 2016. |
European Office Action for EP Application No. 12846553.1 issued Aug. 19, 2016. |
Japanese Examination Report for JP Application No. 2014-540188 dated Jul. 14, 2016. |
Australian Examination Report for AU Application No. 2018201065 dated Jul. 20, 2018. |
Australian Examination Report for AU Application No. 2018201065 dated Jul. 3, 2019. |
Office Action for U.S. Appl. No. 13/762,825 issued Jul. 2, 2014. |
Office Action for U.S. Appl. No. 13/762,825 issued Dec. 12, 2014. |
“Rapid prototyping enables company to manufacture revolutionary new medical product”, accessed at <http://www.newslettersonline.com/user/user.fas/s=63/fp=3/tp=47?T=open_article,565208&P=article>, Oct. 9, 2003. (pp. 1-2). |
“Midlantic Medical Systems—Geo Structure Rectangles (Posterior Approach)” accessed Jun. 11, 2008 at <http://www.midlanticmedical.com/products/anteriorColumnSpacers.php?p=2>. (p. 1). |
“Midlantic Medical Systems—Nexus (Transverse Approach)” accessed Jun. 11, 2008 at <http://www.midlanticmedical.com/products/anteriorColumnSpacers.php?p=4>. (p. 1). |
“Zimmer® Trabecular Metal™ Technology”, accessed at <http://www.zimmerindia.com/z/ctl/op/global/action/1/id/9512/template/PC/navid/8173>, Jul. 9, 2006. (pp. 1-5). |
“Multifunctional Electrochemical Energy Storage Materials”, accessed on Oct. 1, 2008 at <http://www.uvapf.org/technologies/index.cfm/fuseaction/invention/invention_id/85/?CFID=1785971&CFTOKEN=59649784&>. (pp. 1-2). |
“Image: C60a.phg”, Wikipedia, accessed on Oct. 1, 2008 at <http://en.wikipedia.org/wiki/Image:C60a.png″> (pp. 1-3). |
“Image:POV-Ray-Dodecahedron.svg”, Wikipedia, accessed at on Oct. 1, 2008 at <http://en.wikipedia.org/wiki/Image:POV-Ray-Dodecahedron.svg>. (pp. 1-4). |
“Image:Icosahedron.svg”, Wikipedia, accessed on Oct. 1, 2008 at <http://en.wikipedia.org/wiki/Image:Icosahedron.svg>. (pp. 1-2). |
“Image:Octahedron.svg”, Wikipedia, accessed on Oct. 1, 2008 at <http://en.wikipedia.org/wiki/Image:Octahedron.svg>. (pp. 1-3). |
“Truss” Wikipedia, accessed at <http://en.wikipedia.org/wiki/Truss>, Dec. 16, 2009. (pp. 1-9). |
“NexGen Trabecular Metal Tibial Cone Augments” accessed at <http://catalog.zimmer.com/content/zpc/products/200/250/C60/CE008/2653.html>, Nov. 17, 2009. (p. 1). |
“Spinal Kinetics”, accessed on Oct. 6, 2009 at <http://www.spinalkinetics.com/m6systems.html>. (p. 1). |
“CINN”, accessed on Oct. 6, 2009 at <http://www.cinn.org/cr-articles/CR-artificial-disc.html>, Copyright 2008. (pp. 1-9). |
“Zimmer Anatomical Shoulder Fracture System”, copyright 2007. (pp. 1-6). |
“Wolff's Law”, Wikipedia, accessed at <http://en.wikipedia.org/wiki/Wolff's_law>, Jun. 9, 2010. (pp. 1-2). |
“e-Manufacturing is making its inroad to series production”, Nov. 20, 2008. (pp. 1-2). |
“InFix Anterior Lumbar Device” Dec. 17, 2009. (p. 1). |
“Biofoam Wedge System” Wright, Copyright 2010. (pp. 1-4). |
“LPT2 Great Toe Implant” Wright, Copyright 2008. (p. 1-16). |
“Biofoam Wedge System Surgical Technique” Wright, Copyright 2010. (pp. 1-12). |
Murr et al. “Next-generation biomedical implants using additive manufacturing of complex, cellular and functional mesh arrays”, Philosophical Transactions of the Royal Society, Mar. 22, 2010, vol. 368, No. 1917, pp. 1999-2032. |
Yan, et al. “Mechanical strain regulates osteoblast proliferation through integrin-mediated ERK activation”, PloS One, Apr. 23, 2012, vol. 7, No. 4, Article No. e35709. |
Distension Blog located at htpp://kineticdistensio.blogspot.com/2011_10_0_archive.html including entry of Oct. 14, 2011. |
Baranovskaya et al. Itech M. Sc. Programme-Uni Stuttgart, Institut Fur Computerbasiertes Entwerfen (ICD, Stuttgart, Germany located at htpp://architecture-is-yes.tumblr.com/post/8525760 accessed Aug. 21, 2015. |
Cobos et al. “The Cylindrical Titanium Mesh Cage for Treatment of a Long Bone Segmental Defect: Description of a New Technique and Report of Two Cases” Journal of Orthopaedic Trauma (2000) vol. 14, No. 1, pp. 54-59. |
Lindsey et al. “The Efficacy of Cylindrical Titanium Mesh Cage for the Reconstruction of a Critical-Size Canine Segmental Remoral Diaphyseal Defect” Journal of Orthopaedic Research (Jul. 2006), pp. 1438-1453. |
Office Action for U.S. Appl. No. 12/640,825 issued Aug. 30, 2012. |
EPO International Search Report and Written Opinion for PCT/US2009/068512 mailed May 12, 2010. (pp. 1-61). |
International Preliminary Report on Patentability for PCT/US2009/068512 dated Mar. 31, 2011. (pp. 1-8). |
Office Action for U.S. Appl. No. 12/960,092 issued Aug. 20, 2014. |
Office Action for U.S. Appl. No. 12/960,092 issued Apr. 24, 2015. |
Australian Examination Report for Australian Patent Application No. 2009335771 dated Jan. 14, 2014. |
Canadian Examination Report for Canadian Patent Application No. 2,746,505 dated Dec. 1, 2015. |
European Examination Report for EP Application No. 09796208.8 dated Feb. 7, 2014. |
European Examination Report for EP Application No. 09796208.8 dated Aug. 21, 2014. |
Office Action for U.S. Appl. No. 14/743,555 issued Sep. 27, 2016. |
Final Office Action for U.S. Appl. No. 14/743,555 issued Jul. 3, 2017. |
Office Action for U.S. Appl. No. 14/743,579 issued Apr. 5, 2016. |
Office Action for U.S. Appl. No. 14/743,607 issued Apr. 6, 2016. |
Final Office Action for U.S. Appl. No. 14/743,607 issued Sep. 12, 2016. |
Office Action for U.S. Appl. No. 14/743,607 issued Jun. 7, 2017. |
Final Office Action for U.S. Appl. No. 14/743,607 issued Apr. 6, 2018. |
Office Action for U.S. Appl. No. 14/743,607 issued Dec. 14, 2018. |
Final Office Action for U.S. Appl. No. 14/743,607 issued Jun. 10, 2019. |
Office Action for U.S. Appl. No. 14/743,607 issued Jan. 13, 2020. |
Final Office Action for U.S. Appl. No. 14/743,607 issued Aug. 4, 2020. |
Australian Examination Report for Australian Patent Application No. 2013323602 dated Jul. 4, 2017. |
Office Action for U.S. Appl. No. 15/721,940 issued Jun. 29, 2018. |
Office Action for U.S. Appl. No. 15/721,940 issued Mar. 26, 2019. |
Final Office Action for U.S. Appl. No. 15/721,940 issued Oct. 16, 2019. |
International Search Report and Written Opinion for PCT/US2020/60759 issued Feb. 17, 2021. |
International Search Report and Written Opinion for PCT/US2021/023782 issued Jul. 1, 2021. |
Office Action for U.S. Appl. No. 13/762,825 issued Mar. 7, 2016. |
Office Action for U.S. Appl. No. 13/762,825 issued Sep. 20, 2016. |
International Search Report and Written Opinion for PCT/US2013/025281 issued May 15, 2013. |
International Preliminary Report on Patentability for PCT/US2013/025281 issued Aug. 12, 2014. |
Australian Examination Report for AU Application No. 2013216947 dated Mar. 27, 2017. |
Australian Examination Report for AU Application No. 2013216947 dated Feb. 16, 2018. |
Canadian Examination Report for CA Application No. 2,863,865 dated Oct. 5, 2018. |
Canadian Examination Report for CA Application No. 2,863,865 dated Jun. 5, 2020. |
European Examination Report for EP Application No. 13746753.6 dated Sep. 23, 2015. |
European Examination Report for EP Application No. 13746753.6 dated Oct. 28, 2016. |
Japanese Examination Report for JP Application No. 2014-556705 dated Nov. 29, 2016. |
Japanese Examination Report for JP Application No. 2014-556705 dated Sep. 19, 2017. |
Office Action for U.S. Appl. No. 15/463,458 issued Dec. 26, 2017. |
Final Office Action for U.S. Appl. No. 15/463,458 issued Oct. 24, 2018. |
Japanese Examination Report for JP Application No. 2018-006991 dated Nov. 20, 2018. |
Japanese Examination Report for JP Application No. 2018-006991 dated Nov. 12, 2019. |
Australian Examination Report for AU Application No. 2018202175 dated Nov. 22, 2018. |
Australian Examination Report for AU Application No. 2018202175 dated Aug. 23, 2019. |
Office Action for U.S. Appl. No. 14/036,974 issued Jul. 22, 2015. |
International Search Report and Written Opinion for PCT/US2013/061725 issued Jan. 13, 2014. |
International Preliminary Report on Patentability for PCT/US2013/061725 issued Mar. 13, 2015. |
Canadian Examination Report for CA Application No. 2,889,063 dated Sep. 20, 2019. |
Canadian Examination Report for CA Application No. 2,889,063 dated Jul. 31, 2020. |
Chinese Examination Report for CN Application No. 20130055597.3 dated Apr. 5, 2016. |
Chinese Examination Report for CN Application No. 20130055597.3 dated Nov. 16, 2016. |
Chinese Examination Report for CN Application No. 20130055597.3 dated Jun. 8, 2017. |
Extended European Search Report for European Application No. 13843010.3 dated Apr. 16, 2019. |
Third Party Observations for European Application No. 13843010.3 dated Jan. 30, 2020. |
Korean Office Action for Korean Application No. 10-2015-7010324 dated May 18, 2020. |
Japanese Examination Report for JP Application No. 2013-533302 dated Aug. 15, 2017. |
Australian Examination Report for AU Application No. 2013323602 dated Jul. 4, 2017. |
Office Action for U.S. Appl. No. 14/215,961 issued Mar. 11, 2016. |
International Search Report and Written Opinion for PCT/US2014/030319 issued Apr. 6, 2015. |
International Preliminary Report on Patentability for PCT/US2014/030319 issued Sep. 15, 2015. |
Office Action for U.S. Appl. No. 14/216,087 issued Aug. 27, 2015. |
Office Action for U.S. Appl. No. 14/216,087 issued Jul. 14, 2016. |
Office Action for U.S. Appl. No. 14/216,087 issued Feb. 2, 2017. |
International Search Report and Written Opinion for PCTUS201430358 issued Aug. 27, 2014. |
International Preliminary Report on Patentability for PCTUS201430358 issued Sep. 15, 2015. |
Canadian Examination Report for CA Application No. 2,911,880 dated Mar. 26, 2021. |
Chinese Examination Report for CN Application No. 201480026652.0 dated Dec. 2, 2016. |
Chinese Examination Report for CN Application No. 201480026652.0 dated Jul. 31, 2017. |
European Examination Report for EP Application No. 14762747 dated Jan. 26, 2017. |
Japanese Examination Report for JP Application No. 2016-503373 dated Jan. 29, 2018. |
Japanese Examination Report for JP Application No. 2016-503373 dated Dec. 17, 2018. |
Korean Office Action for KR Application No. 10-2015-7029384 dated Oct. 22, 2020. |
Japanese Examination Report for JP Application No. 2019-147711 dated Jul. 22, 2020. |
Office Action issued in Canadian Application No. 2,911,880 dated Mar. 26, 2021. |
International Search Report and Written Opinion for PCT/US2020/58330 issued Jan. 29, 2021. |
Supplemental European Search Report for EP 20881485.5 dated Oct. 4, 2024, 8 pgs. |
Rosen, Dr. David, et al., Design of General Lattice Structures for Lightweight and Compliance Applications, Jul. 5, 2006, Rapid Manufacturing Conference, Loughborough University, Jul. 5-6, 2006, 14 pgs. |
HRL Announces Extraordinary New Lightweight Materials, HRL Laboratories | News, Oct. 29, 2007, 2 pgs. |
Lefebvre, Louis-Philippe, et al., Porous Metals and Metallic Foams: Current Status and Recent Developments, Sep. 17, 2008, Advanced Engineering Materials 2008, 10, No. 9, pp. 775-787. |
Number | Date | Country | |
---|---|---|---|
20210161670 A1 | Jun 2021 | US |
Number | Date | Country | |
---|---|---|---|
62927682 | Oct 2019 | US | |
62935939 | Nov 2019 | US | |
61801597 | Mar 2013 | US | |
61705403 | Sep 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15695122 | Sep 2017 | US |
Child | 15991272 | US | |
Parent | 15057195 | Mar 2016 | US |
Child | 15695122 | US | |
Parent | 14036974 | Sep 2013 | US |
Child | 15057195 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15991272 | May 2018 | US |
Child | 17085407 | US |